Bristol Myers petitions the Supreme Court in a final bid to prove Gilead’s Kite infringed on CAR-T patents

Five years after Juno and Sloan Kettering launched a bitterly fought legal campaign against Gilead’s Kite Pharma, claiming the biotech rival had infringed on its CAR-T patents on the way to launching a pioneering cancer therapy, Bristol Myers Squibb is taking the case all the way to the Supreme Court.


Click to view original post